ConductScience.org, home

Paper19088870

Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma.

Quartuccio L and 10 others. Open Rheumatol J, 2008. Cited by 43 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma. Papers, record 19088870. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19088870

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma.
PubMed
Journal
Open Rheumatol J
PubMed
Year
2008
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
0.9
iCite
Revised in PubMed
2021-10-20
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Quartuccio LLuca
2Fabris MMartina
3Moretti MMassimo
4Barone FFrancesca
5Bombardieri MMichele
6Rupolo MMaurizio
7Lombardi SSandra
8Pitzalis CCostantino
9Beltrami CACarlo Alberto
10Curcio FFrancesco
11De Vita SSalvatore

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115645755Treatment of B-cell lymphoma with rituximab in two patients with Sjögren's syndrome associated with hepatitis C virus infection.Lupus2004https://conductscience.org/library/papers/15645755PubMed
216508933Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.Arthritis Rheum2006https://conductscience.org/library/papers/16508933PubMed
316950808Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.Ann Rheum Dis2007https://conductscience.org/library/papers/16950808PubMed
417393395Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.Arthritis Rheum2007https://conductscience.org/library/papers/17393395PubMed
515448217Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome.Rheumatology (Oxford)2004https://conductscience.org/library/papers/15448217PubMed
615251985Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.Blood2004https://conductscience.org/library/papers/15251985PubMed
710805354Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.Semin Arthritis Rheum2000https://conductscience.org/library/papers/10805354PubMed
812006334Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.Ann Rheum Dis2002https://conductscience.org/library/papers/12006334PubMed
915187246Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.Rheumatology (Oxford)2004https://conductscience.org/library/papers/15187246PubMed
1016322082
Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Ann Rheum Dis2006https://conductscience.org/library/papers/16322082PubMed
1115634903Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy.J Immunol2005https://conductscience.org/library/papers/15634903PubMed
1215576414Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.Ann Rheum Dis2005https://conductscience.org/library/papers/15576414PubMed
1315550531Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.Ann Rheum Dis2005https://conductscience.org/library/papers/15550531PubMed
1412794796Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphoma.Arthritis Rheum2003https://conductscience.org/library/papers/12794796PubMed
1512525388The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome.Ann Rheum Dis2003https://conductscience.org/library/papers/12525388PubMed
1617469105BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.Arthritis Rheum2007https://conductscience.org/library/papers/17469105PubMed
1711778660
Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach.
Blood Cells Mol Dis2001https://conductscience.org/library/papers/11778660PubMed
1814673998B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.Arthritis Rheum2003https://conductscience.org/library/papers/14673998PubMed
198090760Long-term culture and functional characterization of follicular cells from adult normal human thyroids.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8090760PubMed
208523344Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome.J Rheumatol1995https://conductscience.org/library/papers/8523344PubMed

See all 23 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
40884054Role of Fibroblast-Immune Crosstalk in Kidney, Lung, and Skin Tertiary Lymphoid Structures.Immunol Rev2025https://conductscience.org/library/papers/40884054PubMed
37176092B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma.Int J Mol Sci2023https://conductscience.org/library/papers/37176092PubMed
35689679Role of tertiary lymphoid organs in the regulation of immune responses in the periphery.Cell Mol Life Sci2022https://conductscience.org/library/papers/35689679PubMed
34788412Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?Rheumatology (Oxford)2022https://conductscience.org/library/papers/34788412PubMed
33297481Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.Cells2020https://conductscience.org/library/papers/33297481PubMed
33072210Diagnostic Abilities for Determining the Level of Blood Cryoglobulins in the Choice of Tactics for Operations on the Small Intestine.J Med Life2020https://conductscience.org/library/papers/33072210PubMed
31213547Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/31213547PubMed
30472652Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome.Ann Rheum Dis2019https://conductscience.org/library/papers/30472652PubMed
30258435Tertiary Lymphoid Structures: Autoimmunity Goes Local.Front Immunol2018https://conductscience.org/library/papers/30258435PubMed
29228031Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.PLoS One2017https://conductscience.org/library/papers/29228031PubMed
28202919Ectopic lymphoid neogenesis in rheumatic autoimmune diseases.Nat Rev Rheumatol2017https://conductscience.org/library/papers/28202919PubMed
26367225Identification and validation of biomarkers associated with acute and chronic graft versus host disease.Bone Marrow Transplant2015https://conductscience.org/library/papers/26367225PubMed
23566754B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.Arthritis Res Ther2013https://conductscience.org/library/papers/23566754PubMed
22611237A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.J Immunol2012https://conductscience.org/library/papers/22611237PubMed
20148068Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation.Int J Rheumatol2009https://conductscience.org/library/papers/20148068PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19088870

GET https://conductscience.org/api/papers/v1/19088870/references?page=2